Aquestive Therapeutics (AQST) director receives 50,500 stock options grant

Rhea-AI Filing Summary

Aquestive Therapeutics director Gregory B. Brown reported an equity compensation award. He received a grant of stock options covering 50,500 shares of Common Stock at an exercise price of $3.99 per share.

The options vest 100% on June 10, 2027, subject to his continuous service with the company through that date. Following this report, he directly holds 75,085 shares of Common Stock and the newly granted 50,500 stock options.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider BROWN GREGORY B

Role null

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Purchase)	50,500	$0.00	--
holding	Common Stock	--	--	--

Holdings After Transaction: Stock Option (Right to Purchase) — 50,500 shares (Direct, null); Common Stock — 75,085 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Common shares held: 75,085 shares Options granted: 50,500 options Exercise price: $3.99 per share +2 more

5 metrics

Common shares held 75,085 shares Directly owned after reported transactions

Options granted 50,500 options Stock Option (Right to Purchase) grant on Common Stock

Exercise price $3.99 per share Conversion or exercise price of the stock options

Vesting date June 10, 2027 100% of underlying shares vest on this date

Expiration date June 10, 2036 Stock options expiration

Key Terms

Stock Option (Right to Purchase), Common Stock, vesting, exercise price

4 terms

Stock Option (Right to Purchase) financial

"security_title: "Stock Option (Right to Purchase)""

Common Stock financial

"underlying_security_title: "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

vesting financial

"The shares underlying the options vest as follows: 100% of the underlying shares vest June 10, 2027"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

exercise price financial

"conversion_or_exercise_price: "3.9900""

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

BROWN GREGORY B

(Last) (First) (Middle)

C/O AQUESTIVE THERAPEUTICS, INC.

30 TECHNOLOGY DRIVE

(Street)

WARREN NEW JERSEY 07059

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Aquestive Therapeutics, Inc. [ AQST ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock								75,085	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Purchase)	$3.99	06/10/2026		A		50,500		06/10/2027(1)	06/10/2036	Common Stock	50,500	$0	50,500	D

Explanation of Responses:

1. The shares underlying the options vest as follows: 100% of the underlying shares vest June 10, 2027, subject to Dr. Brown's continuous service with the Issuer from the grant date through the applicable vesting date.

Remarks:

	/s/ Thomas Zalewski, as Attorney-In-Fact	06/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Gregory B. Brown report at Aquestive Therapeutics (AQST)?

Gregory B. Brown reported receiving a stock option grant at Aquestive Therapeutics. The award covers 50,500 options on Common Stock as compensation, not an open-market purchase or sale, and reflects an increase in his potential future ownership if the options are exercised.

How many stock options did Gregory B. Brown receive from Aquestive Therapeutics (AQST)?

He received a grant of 50,500 stock options. Each option relates to one share of Common Stock and carries an exercise price of $3.99 per share, providing potential future equity if the company’s share price exceeds that level after vesting.

What is the vesting schedule for Gregory B. Brown’s new AQST stock options?

The options vest 100% on June 10, 2027. Vesting is conditioned on Dr. Brown’s continuous service with Aquestive Therapeutics from the grant date through that vesting date, aligning the award with his ongoing role at the company.

What are Gregory B. Brown’s reported holdings in Aquestive Therapeutics (AQST) after this filing?

After this filing, he directly holds 75,085 shares of Common Stock and 50,500 stock options. The options are exercisable at $3.99 per share after vesting, which could increase his ownership if exercised in the future.

Is Gregory B. Brown’s AQST stock option grant an open-market buy or sell?

No, the transaction is a stock option grant categorized as a grant, award, or other acquisition. It represents equity-based compensation from Aquestive Therapeutics rather than an open-market purchase or sale of existing shares.